What Todd Blanche’s Attorney General Nomination Could Mean for Psychedelics
A recent JD Supra analysis looks at what Todd Blanche’s nomination for attorney general could mean for marijuana and psychedelic
Read MoreMarket updates, company news, pharmaceutical developments, and industry trends.
A recent JD Supra analysis looks at what Todd Blanche’s nomination for attorney general could mean for marijuana and psychedelic
Read More
The psychedelic drugs market is poised for explosive growth, with projections going from $3.63 billion in 2024 to $10.11 billion
Read More
The FDA's decision could deliver the first psychedelic medicine approved by the FDA as soon as this summer.
Read More
One of the country’s most influential anesthesia groups is warning that ketamine telehealth's safety standards have not kept pace.
Read More
The global market for these compounds reached $4.75 billion in 2025. Analysts project growth to $16.93 billion by 2034.
Read More
Trump’s executive order on psychedelics pushed a once fringe issue into the center of health policy. The coverage shows a
Read More
Psychedelics are no longer a fringe topic among veterans. They are part of the lived experience of millions of those
Read More
The compounded GLP-1 market has become fiercely competitive. Most clinics compete on price and speed. Mindful Labs wants to change
Read More
A healthcare-specific Google Maps playbook for ketamine clinics — GBP, citations, reviews, and the 5 generic SEO tactics to skip.
Read More
Can MDMA assisted therapy safely help veterans living with both PTSD and alcohol use disorder? The VA Hopes to find
Read More